Brief: Qlife Granted Its First Patent For Egoo.Health Device

Qlife Holding AB

25/01/2021 07:03

Jan 25 (Reuters) - Qlife Holding AB  QLIFE.ST :
    * QLIFE GRANTED ITS FIRST PATENT FOR EGOO.HEALTH DEVICE
    * TODAY THAT IT'S PATENT APPLICATION THAT PROTECTS BIOMARKER
DETECTION UNIT OF EGOO.HEALTH PLATFORM HAS BEEN GRANTED IN
DENMARK.
    * DANISH PATENT OFFICE HAS GRANTED QLIFE PATENT NUMBER
DK180348 B1
FOR ITS BIOMARKER DETECTION UNIT
    * NEW PATENT IS VALID UNTIL 2039 AND GIVES QLIFE A STRONGER
INTELLECTUAL PROPERTY POSITION AS COMPANY ENTERS
COMMERCIALIZATION.
    * ADDITIONAL PATENT APPLICATIONS FOR QLIFE'S EGOO.HEALTH
PLATFORM
ARE CURRENTLY BEING PROCESSED BY PATENT AUTHORITIES IN SEVERAL
LARGE INTERNATIONAL MARKETS, SUCH AS US, CHINA AND JAPAN.

Source text for Eikon:  ID:nWkr4shjT2 
Further company coverage:  QLIFE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))